# Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Canonical URL: https://biopharmsignal.com/news/DRMA/dermata-therapeutics-provides-corporate-update-and-reports-financial-results-for-the-first-quarter-2026
Ticker: DRMA
Company: Dermata Therapeutics
Source: Dermata Therapeutics
Published: 2026-05-13 20:05 EST
Original Source URL: https://ir.dermatarx.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-13 20:05 EST — [Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026](https://biopharmsignal.com/news/DRMA/dermata-therapeutics-provides-corporate-update-and-reports-financial-results-for-the-first-quarter-2026) — Source: Dermata Therapeutics
- 2026-04-02 12:30 EST — [Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System](https://biopharmsignal.com/news/DRMA/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system) — Source: Dermata Therapeutics
- 2026-03-26 21:15 EST — [Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025](https://biopharmsignal.com/news/DRMA/dermata-therapeutics-provides-corporate-update-and-reports-financial-results-for-the-year-ended-2025) — Source: Dermata Therapeutics
- 2026-03-10 12:30 EST — [Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing](https://biopharmsignal.com/news/DRMA/dermata-announces-appointment-of-kyra-peckaitis-as-vice-president-marketing) — Source: Dermata Therapeutics
- 2026-03-05 14:00 EST — [Dermata Opens a New Chapter with the Release of Tome Skincare](https://biopharmsignal.com/news/DRMA/dermata-opens-a-new-chapter-with-the-release-of-tome-skincare) — Source: Dermata Therapeutics
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)